Company Overview

Imperial Brands PLC, together with its subsidiaries, manufactures, imports, markets, and sells tobacco and tobacco-related products in Europe, Americas, Africa, Asia, and Australasia. It offers a range of cigarettes, fine cut and smokeless tobacco, papers, and cigars; and next generation product (NGP) portfolio, such as e-vapour products, oral nicotine, and heated tobacco products. The company sells its products under various brands, including Davidoff, Gauloises, JPS, West, L&B, Winston, Parker & Simpson, blu, Pluze, Zone-X, Kool, Horizon, Backwoods, Skruf, Golden Virginia, Rizla, and Dutch Masters. It also engages in the distribution of tobacco and NGP products for tobacco and NGP product manufacturers; and various non-tobacco and NGP products and services. In addition, the company is involved in the management of a golf course; distribution of pharmaceuticals, POS software, and published materials and other products; printing and publishing activities; and provision of long haul transportation, industrial parcel and express delivery, advertising, and support management services. Further, it owns the trademarks; and retails its products. The company was formerly known as Imperial Tobacco Group PLC and changed its name to Imperial Brands PLC in February 2016. Imperial Brands PLC was founded in 1901 and is based in Bristol, the United Kingdom.

  • Name

    Imperial Brands PLC

  • CEO

    Mr. Stefan Bomhard

  • Website

    www.imperialbrandsplc.com

  • Sector

    Tobacco

  • Year Founded

    1636

Profile

  • Market Cap

    £18.85B

  • EV

    £29.83B

  • Shares Out

    839.92M

  • Revenue

    £18.18B

  • Employees

    25,200

Margins

  • Gross

    36.78%

  • EBITDA

    20.38%

  • Operating

    17.58%

  • Pre-Tax

    15.47%

  • Net

    11.44%

  • FCF

    14.99%

Returns (5Yr Avg)

  • ROA

    6.12%

  • ROTA

    1.34%

  • ROE

    32.06%

  • ROCE

    16.5%

  • ROIC

    9.53%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    £23.96

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    £668M

  • Net Debt

    £10.4B

  • Debt/Equity

    2.18

  • EBIT/Interest

    7.47

Growth (CAGR)

  • Rev 3Yr

    2.34%

  • Rev 5Yr

    3.03%

  • Rev 10Yr

    2.46%

  • Dil EPS 3Yr

    -7.65%

  • Dil EPS 5Yr

    7.31%

  • Dil EPS 10Yr

    12.97%

  • Rev Fwd 2Yr

    1.13%

  • EBITDA Fwd 2Yr

    1.83%

  • EPS Fwd 2Yr

    8.63%

  • EPS LT Growth Est

    10%

Dividends

  • Yield

  • Payout

    63.98%

  • DPS

    £1.49

  • DPS Growth 3Yr

    2.45%

  • DPS Growth 5Yr

    -5.15%

  • DPS Growth 10Yr

    2.16%

  • DPS Growth Fwd 2Yr

    4.6%

LSE:IMB